.png | width = 200 | CAS_number = 85622-93-1 | ATC_prefix = L01 | ATC_suffix = AX03 | ATC_supplemental = | PubChem = 5394 | DrugBank = APRD00557 | chemical_formula = C6H6N6O2 | molecular_weight = 194.151 g/mol | bioavailability = | protein_bound = 15% | metabolism = Temozolomide is spontaneously hydrolized at physiologic pH to the active species, 3-methyl-(triazen-1-yl)imidazole-4-carboxamide (MTIC) and to temozolomide acid metabolite. | elimination_half-life = Temozolomide is rapidly eliminated with a mean elimination half-life of 1.8 hours and exhibits linear kinetics over the therapeutic dosing range. | pregnancy_category = | legal_status = Approved by the FDA on August 11, 1999. Available by prescription only. | routes_of_administration = Oral }}

Temodar - Temozolomide. A chemotherapeutic drug indicated for treatment of adults with anaplastic astrocytoma at first relapse with disease progression on a nitrosourea- and procarbazine containing drug regimen.
Temozolomide - Familydoctor.org - Information for patients in English and Spanish.